Navigation Links
Global Bioenergies is Setting-Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Renewable Resources

EVRY, October 13 /PRNewswire/ -- Philippe Marliere, cofounder and initiator of the project, has announced the establishment of the scientific advisory board:

    - Dr. Bernard Badet heads a research group at the Institut de
      Chimie des Substances Naturelles (Gif-sur-Yvette, France) that is
      interested in the understanding of the enzyme mechanism towards the
      development of chemical tools for diagnostic and therapeutic purposes.

    - Prof. Donald Hilvert heads a research group at the ETH
      Zurich (Zurich, Switzerland). His research program focuses on
      understanding how enzymes work and evolve and on mimicking the
      properties of these remarkable catalysts in the laboratory.

    - Prof. Jean-Marc Paris led the R&D division responsible for
      antibiotic discovery at Rhone Poulenc Rorer before joining Rhodia,
      where he worked as Scientific Director for organic chemistry and
      biotechnologies. He is honorary Professor at the Ecole Nationale
      Superieure de Chimie de Paris.

    - Prof. Dieter Soll heads a research laboratory at Yale
      University in New Haven (Connecticut, USA), investigating the
      biocatalytic and evolutionary basis of protein biosynthesis. Prof. Soll
      is a member of the US Academy of Sciences.

    - Dr. Jean Weissenbach is the Director of Genoscope, the
      French genome sequencing center, which he founded in 1997. Now part of
      the Genomics Institute of the CEA, Genoscope is searching new enzyme
      activities using genomics and large scale experimentation. Dr.
      Weissenbach is a member of the French Academy of Sciences.

Global Bioenergies, located on the Genopole campus close to Paris, has today announced the proof-of-concept of a synthetic metabolic pathway for producing isobutene, a key building block that can be converted into transportation fuels, polymers and various commodity chemicals.

Macha Anissimova, Head of Research, said "We are very proud to have reached this key milestone in advance on schedule. We have benefited from the assistance of Genoscope and of the analytical chemistry platform of Evry-Val d'Essonne University. The bioproduction of a gaseous hydrocarbon will make it possible to obtain pure products at high yield and low cost.".

According to Prof. Dieter Soll, "The data on isobutene formation presented by Global Bioenergies are convincing, and I am now impatient to see the process optimized and scaled up."

"Development of such an artificial metabolic pathway represents a signal accomplishment with enormous implications. Standard technologies for enzyme and metabolic engineering can now be applied to transform this proof of concept into a viable industrial process," added Prof. Donald Hilvert.

Marc Delcourt, cofounder and CEO of the company concludes: "We are now focusing on industrializing the process, which will be financed through a second round currently in preparation."

Please visit our new web site:

SOURCE Global Bioenergies

SOURCE Global Bioenergies
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care
2. Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
3. Biotechnology Can Address Global Mega Trends, DuPont Leader Says
4. Environmental & Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering
5. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
6. Global Biofuels Growth to Double by 2015
7. DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
8. Global Public Health the Focus of Scientific Conference
9. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
10. Cell Therapeutics Added to the NASDAQ OMX Global Biotechnology Index
11. Fortebio, Inc. to Present at UBS Global Life Sciences Conference
Post Your Comments:
(Date:11/30/2015)... BOCA RATON, Florida and MAGDEBURG, Germany ... European Congress of NeuroRehabilitation (ECNR) in Vienna, ... --> 3rd European Congress of NeuroRehabilitation (ECNR) in ... 1-4, 2015. --> NovaVision, a wholly owned subsidiary ... launching the European version of its Internet-delivered NovaVision Therapy Suite ...
(Date:11/27/2015)... Kingdom , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... company, announced today that it has closed the sale ... business to Guerbet (GBT- NYSE Euronext) in a transaction ... encompassed four manufacturing facilities and a total of approximately ... in the St. Louis area. ...
(Date:11/25/2015)... 2015 --> ... - 2020 report analyzes that automating biobanking workflow ... in long-term samples, minimizing manual errors, improving the ... manual errors such as mislabeling or inaccurate sample ... plays a vital role in blood fractionation, DNA ...
(Date:11/25/2015)...  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... of Neurocrine Biosciences, will be presenting at the 27th ... York . .   ... minutes prior to the presentation to download or install ... be available on the website approximately one hour after ...
Breaking Biology Technology:
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
Breaking Biology News(10 mins):